Clinical Trial

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Study acronym: RETRACE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-01-07; most recent amendment 2025-07-16.
Trial Details
NCT Number NCT06771193
Lead Sponsor MSD Italia S.r.l.
Conditions Cervical Cancer, Locally Advanced Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer
Enrollment 200 participants
Start Date 2024-12-17
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-20